William Mack & Associates’s Constellium CSTM Stock Holding History

William Mack & Associates’s Portfolio CSTM Stock Details CSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$339	Buy	+14	New	+$388	﹤0.01%	824

Other funds holding CSTM

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Bpifrance Maisons Alfort, Cedex, France $1.2B AUM 41.6% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $64.4B AUM 36.06% 1-Year Est. Return

Brightline Capital Management Miami, Florida $247M AUM 101.7% 1-Year Est. Return

William Mack & Associates's CSTM Position: Q3 2026 in Review

William Mack & Associates opened a new position in Constellium (CSTM) in Q3 2026: 14 shares worth $339. The stake represents ﹤0.01% of the portfolio and ranks #824 among its holdings.

277 funds tracked by Wall St. Rank hold CSTM as of Q3 2026.

William Mack & Associates held 14 shares of Constellium worth $339 as of Q3 2026.
Constellium was a new William Mack & Associates position in Q3 2026.
Constellium made up ﹤0.01% of William Mack & Associates's portfolio in Q3 2026, its #824 holding.
277 funds tracked by Wall St. Rank held Constellium as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.